Scientists hunt for genetic clues in familial lung disease

NCT ID NCT07251725

Recruiting now Knowledge-focused Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to uncover the genetic causes of familial pulmonary fibrosis, a progressive lung disease that runs in families. Researchers will analyze DNA from 126 adults with a family history of the condition, looking for gene changes linked to lung scarring. The goal is to improve early diagnosis, genetic counseling, and eventually develop personalized treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could identify genetic markers that help diagnose familial pulmonary fibrosis earlier and point toward new treatment targets for both familial and idiopathic forms.
What could go wrong: This is an observational genetic study, not a treatment trial. It may not directly lead to new therapies, and findings may not apply to all patients with pulmonary fibrosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILIAL PULMONARY FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

idiopathic pulmonary fibrosis inherited interstitial lung disease pulmonary fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FAMILIAL PULMONARY FIBROSIS

Contacts and locations

Locations

Fondazione IRCCS Policlinico San Matteo
RECRUITING

Pavia, Lombardy, 27100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.